Overview Fundamentals API Earnings EOD API Sample Code Pricing

Kadimastem Ltd (KMSTF PINK) stock market data APIs

$6.404 0(0%) as of July 25, 2024
Price chart is built with Anychart

Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel.

Kadimastem Ltd Financial Data Overview

6.404
6.404
-
6.404
6.404
0.6404-6.404
5 606 K
419 K
0
-0.1058
0.418
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'KMSTF',
Type: 'Common Stock',
Name: 'Kadimastem Ltd',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00Z1JVG63',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Kadimastem Ltd Fundamental Data is available in our Financial Data APIs

  • Net Revenue 0
  • EBITDA -10 655 000
  • Earnings Per Share -0.75
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Kadimastem Ltd Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast 0

Get Kadimastem Ltd End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com